Community-based opioid overdose prevention programs providing naloxone - United States, 2010

Morbidity and Mortality Weekly Report

Volumn 61, Issue 6, 2012, Pages 101-105

  Wheeler, Eliza ^a   Davidson, Peter J ^b   Stephen Jones, T ^c   Irwin, Kevin S ^d  

^a Drug Overdose Prevention and Education (DOPE) Project   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Public Health Consulting   (United States)

^d TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ARTICLE; COMMUNITY CARE; HUMAN; INFORMATION PROCESSING; INTOXICATION; OPIATE ADDICTION; STATISTICS; UNITED STATES;

ANALGESICS, OPIOID; COMMUNITY HEALTH SERVICES; DATA COLLECTION; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; OVERDOSE; UNITED STATES;

EID: 84857382804     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. CDC. WONDER [Database]. Atlanta, GA: US Department of Health and Human Services, CDC; 2012. Available at http://wonder.cdc.gov. Accessed February 13, 2012.
2. Hardman JG, Limbird LE, eds. Goodman and Gilman's the pharmacologic basis of therapeutics. 11th ed. New York, NY: McGraw-Hill; 2006:576-8.
3. Wermeling DP. Opioid harm reduction strategies: focus on expanded access to intranasal naloxone [Editorial]. Pharmacotherapy 2010; 30:627-31.
4. Lagu T, Anderson BJ, Stein M. Overdoses among friends: drug users are willing to administer naloxone to others. J Subst Abuse Treat 2006; 30:129-33.
5. Doe-Simkins M, Walley AY, Epstein A, Moyer P. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health 2009;99:788-91.
6. Enteen L, Bauer J, McLean R, et al. Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health 2010; 8:931-41.
7. Young AM, Havens JR, Leukefeld CG. Route of administration for illicit prescription opioids: a comparison of rural and urban drug users. Harm Reduct J 2010;7:24.
8. Albert S, Brason FW, Sanford CK, Dasgupta N, Graham J, Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med 2011;12(Suppl 2):S77-85.
9. Burris S, Beletsky L, Castagna C, Coyle C, Crowe C, McLaughlin J. Stopping an invisible epidemic: legal issues in the provision of naloxone to prevent opioid overdose. Drexel L Rev 2009;1:273-340.
10. The Global Fund to Fight AIDS, Tuberculosis and Malaria. Harm reduction for people who use drugs: information note. June 2011. Available at http://www.theglobalfund.org/documents/rounds/11/r11_harmreduction_infonote_en. Accessed on February 13, 2012.